Trial Profile
Stusy of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2018
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 24 Aug 2018 New trial record
- 17 Aug 2018 Results published in the British Journal of Dermatology